BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14698652)

  • 1. Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.
    Shmeleva VM; Kapustin SI; Papayan LP; Sobczyńska-Malefora A; Harrington DJ; Savidge GF
    Thromb Res; 2003; 111(6):351-6. PubMed ID: 14698652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
    Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Hyperhomocysteinemia by Methylenetetrahydrofolate Reductase C677T Polymorphism in Chinese Patients With Hypertension.
    Wang Y; Xu X; Huo Y; Liu D; Cui Y; Liu Z; Zhao Z; Xu X; Liu L; Li X; Jiang S
    Clin Appl Thromb Hemost; 2015 Oct; 21(7):661-6. PubMed ID: 24459043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
    Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
    Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
    Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
    Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
    Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):869-73. PubMed ID: 26083986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
    Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.
    Khandanpour N; Willis G; Meyer FJ; Armon MP; Loke YK; Wright AJ; Finglas PM; Jennings BA
    J Vasc Surg; 2009 Mar; 49(3):711-8. PubMed ID: 19157768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India.
    Kumar M; Goudihalli S; Mukherjee K; Dhandapani S; Sandhir R
    Metab Brain Dis; 2018 Oct; 33(5):1617-1624. PubMed ID: 29926428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
    Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects.
    Huang L; Song XM; Zhu WL; Li Y
    Biomed Environ Sci; 2008 Dec; 21(6):514-20. PubMed ID: 19263808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.
    Vuckovic BA; Cabarkapa VS; Ilic TA; Salatic IR; Lozanov-Crvenkovic ZS; Mitic GP
    Croat Med J; 2013 Oct; 54(5):480-8. PubMed ID: 24170727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Genetic Polymorphism of methylenetetrahydrofolate reductase C677T on Development of Hyperhomocysteinemia and Related Oxidative Changes in Egyptian β-Thalassemia Major Patients.
    Abd-Elmawla MA; Rizk SM; Youssry I; Shaheen AA
    PLoS One; 2016; 11(5):e0155070. PubMed ID: 27187171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
    de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
    Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease.
    Zetterberg H; Coppola A; D'Angelo A; Palmér M; Rymo L; Blennow K
    Thromb Res; 2002 Nov; 108(2-3):127-31. PubMed ID: 12590948
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of hyperhomocysteinemia, methylene tetrahydrofolate reductase C677T mutation, and vitamin B12 and folate deficiency in patients with chronic venous insufficiency.
    Sam RC; Burns PJ; Hobbs SD; Marshall T; Wilmink AB; Silverman SH; Bradbury AW
    J Vasc Surg; 2003 Nov; 38(5):904-8. PubMed ID: 14603192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.